NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/14/2025
Back to search
Official data from USPTO
MYELOVAX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
01/14/2025
Trademark type
Word
Nice classes
5
Filing date
12/19/2022
Registration date
01/14/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/14/2025
Last transaction
01/14/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
05/20/2005
First use in commerce
05/20/2005
Drawing code
4
Owner type
03
Owner location
Lehi,, UT, US
Examiner
MCBRIDE, THEODORE
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Meridian Therapeutics Inc.
Representatives
Mark David Torche Patwrite Law
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Human vaccine preparations; Therapeutic vaccines; Vaccine preparations; Vaccines; Veterinary vaccines
Publications
History of USPTO decisions and trademark events.
29 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/14/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12/20/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/20/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/23/2024
IUAF
USE AMENDMENT FILED
11/21/2024
EISU
TEAS STATEMENT OF USE RECEIVED
11/21/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/21/2024
EX1G
SOU EXTENSION 1 GRANTED
08/21/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
08/20/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/02/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/02/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/02/2024
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
06/27/2024
NREV
NOTICE OF REVIVAL - E-MAILED
06/27/2024
PETG
PETITION TO REVIVE-GRANTED
06/27/2024
PROA
TEAS PETITION TO REVIVE RECEIVED
06/27/2024
EXT1
SOU EXTENSION 1 FILED
06/26/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/24/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/24/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/24/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/26/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/31/2023
PUBO
PUBLISHED FOR OPPOSITION
10/31/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/11/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/25/2023
DOCK
ASSIGNED TO EXAMINER
09/20/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/15/2023
NWAP
NEW APPLICATION ENTERED
12/22/2022
Continuous trademark protection
Get notified about every new filing that threatens MYELOVAX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.